{"id":40690,"date":"2023-03-14T12:40:06","date_gmt":"2023-03-14T07:10:06","guid":{"rendered":"http:\/\/finservwealth.com\/eli-lilly-forays-into-dermatological-space-with-launch-of-psoriasis-drug\/"},"modified":"2023-03-14T12:40:06","modified_gmt":"2023-03-14T07:10:06","slug":"eli-lilly-forays-into-dermatological-space-with-launch-of-psoriasis-drug","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/eli-lilly-forays-into-dermatological-space-with-launch-of-psoriasis-drug\/","title":{"rendered":"Eli Lilly forays into dermatological space with launch of psoriasis drug"},"content":{"rendered":"<p> The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).<\/p><div id=\"finse-1574626021\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/eli-lilly-forays-into-dermatological-spacelaunchpsoriasis-drug_16926201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI). The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/eli-lilly-forays-into-dermatological-spacelaunchpsoriasis-drug_16926201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/eli-lilly-forays-into-dermatological-spacelaunchpsoriasis-drug_16926201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI). The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/eli-lilly-forays-into-dermatological-spacelaunchpsoriasis-drug_16926201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-40690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/3\/394521139_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/40690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=40690"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/40690\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=40690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=40690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=40690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}